<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Ketamine</title>
  </titleInfo>
  <name type="personal">
    <namePart>Moghaddam, Bita</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="local">Print books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">mau</placeTerm>
    </place>
    <dateIssued>©2021</dateIssued>
    <dateIssued encoding="marc">2021</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>182 p: 18 cm</extent>
  </physicalDescription>
  <abstract>"A complete and authoritative guide to the science of ketamine, the controversial yet current drug of choice for treating depression, a drug whose efficacy and impact is not yet well-established"--</abstract>
  <tableOfContents>The Molecule Ketamine -- Uses of Ketamine -- Neuroscience of Ketamine -- Ketamine as an Antidepressant -- How Does Ketamine Produce Antidepressant Effects -- Safety Concerns with Ketamine and Esketamine -- Where Do We Go From Here.</tableOfContents>
  <note type="statement of responsibility">Bita Moghaddam.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="mesh">
    <topic>Ketamine</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject authority="mesh">
    <topic>Ketamine</topic>
    <topic>chemistry</topic>
  </subject>
  <subject authority="mesh">
    <topic>Ketamine</topic>
    <topic>pharmacology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Antidepressive Agents</topic>
  </subject>
  <subject authority="mesh">
    <topic>Depressive Disorder</topic>
    <topic>drug therapy</topic>
  </subject>
  <classification authority="lcc">RD86.K4 M64 2021</classification>
  <identifier type="isbn">9780262542241</identifier>
  <identifier type="lccn">2020010212</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">DNLM/DLC</recordContentSource>
    <recordCreationDate encoding="marc">200227</recordCreationDate>
    <recordChangeDate encoding="iso8601">20220117110720.0</recordChangeDate>
    <recordIdentifier source="US-DLC">21450315</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
